Sanjiv Patel insider trades
Open-market stock purchases and sales by Sanjiv Patel, President and CEO at Relay Therapeutics, Inc, from SEC Form 4 filings since Jul 20, 2020.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -32%.